As filed with the Securities and Exchange Commission on November 21, 2002
Registration No. 333-34630
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
Under
The Securities Act of 1933
________________
GENELABS TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Its Charter)
________________
California 94-3010150
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
505 Penobscot Drive
Redwood City, California 94063
(650) 369-9500
(Address, Including Zip Code, of Registrant's Principal Executive Offices)
________________
Heather Criss Keller, Esq.
Genelabs Technologies, Inc.
505 Penobscot Drive
Redwood City, California 94063
(650) 369-9500
(Name, Address and Telephone Number, Including Area Code, of Agent For Service)
________________
Copy to:
Gregory C. Smith, Esq.
Skadden, Arps, Slate, Meagher & Flom LLP
525 University Avenue
Palo Alto, California 94301
(650) 470-4500
________________
Approximate date of commencement of proposed sale to the public: From
time to time after the effective date of this Registration Statement.
If only securities being registered on this form are to be offered
pursuant to dividend or interest reinvestment plans, please check the
following box. [ ]
If any of the securities being registered on this form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
of 1933, other than securities offered only in connection with dividend or
interest reimbursement plans, check the following box. [X]
If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following
box and list the Securities Act of 1933 registration statement number of the
earlier effective registration statement for the same offering. [ ] ___________
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ] ____________
If deliver of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
===============================================================================
EXPLANATORY NOTE
Genelabs Technologies, Inc. (the "Registrant") filed a registration
statement on Form S-3 (Registration No. 333-34630) (the "Registration
Statement"), which originally registered 5,000,000 shares of common stock, no
par value, of the Registrant, to be sold from time to time.
Pursuant to the undertaking in Item 17 of Part II of the Registration
Statement, the Registrant is filing this Post-Effective Amendment No. 1 to the
Registration Statement to deregister the 120,729 shares of common stock
registered by the Registration Statement that remain unsold as of the date
hereof.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as
amended, the Registrant certifies that it has reasonable grounds to believe
that, at the time the Registration Statement was filed, it met all of the
requirements for filing on Form S-3 and has duly caused this Post-Effective
Amendment No. 1 to the Registration Statement to be signed on its behalf by
the undersigned, thereunto duly authorized, in Redwood City, California, on
this 21st day of November, 2002.
GENELABS TECHNOLOGIES, INC.
By: /s/ Irene A. Chow
-------------------------------
Name: Irene A. Chow
Title: Chairman, Chief Executive
Officer and Director
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 1 to the Registration Statement has been signed
by the following persons in the capacities and on the dates indicated.
Signature Title Date
--------- ----- ----
/s/ Irene A. Chow
- ------------------------ Chairman, Chief Executive November 21, 2002
Irene A. Chow Officer and Director
/s/ Matthew M. Loar
- ------------------------ Chief Financial Officer November 21, 2002
Matthew M. Loar
*
- ------------------------ Director November 21, 2002
J. Richard Crout
*
- ------------------------ Director November 21, 2002
Thomas E. Dewey, Jr.
*
- ------------------------ Director November 21, 2002
Arthur Gray, Jr.
- ------------------------ Director November 21, 2002
H. H. Haight
*
- ------------------------ Director November 21, 2002
Alan Y. Kwan
*
- ------------------------ President and Director November 21, 2002
James A. D. Smith
- ------------------------ Director November 21, 2002
Nina K. Wang
* By: /s/ Irene A Chow
------------------------
Irene A. Chow
Attorney-in-Fact